A Booming Industry Without Basic Tracking (Image Credits: Foodsafetynews.com)
Washington – U.S. Senate Democratic Whip Dick Durbin reintroduced the Dietary Supplement Listing Act on January 15, requiring manufacturers to submit product details to the Food and Drug Administration for a public database.[1][2]
A Booming Industry Without Basic Tracking
The dietary supplement market has exploded since 1994. Sales grew from $4 billion to more than $50 billion annually.[1] The number of products jumped from 4,000 to an estimated 100,000.[1]
That year, Congress passed the Dietary Supplement Health and Education Act, or DSHEA. The law granted FDA oversight powers but stopped short of mandating product registration. FDA officials now lack a clear picture of what reaches store shelves or online platforms.
More than 75 percent of American adults consume supplements. Yet regulators received over 2,000 adverse event reports in 2023 alone. Experts estimate the true figure tops 50,000 yearly due to underreporting.[1]
Key Provisions of the Legislation
The bill targets that information gap. Manufacturers would submit specifics before selling products interstate.
Requirements include:
- Product names
- Full ingredient lists
- Electronic label copies
- Allergen statements
- Health and structure/function claims
FDA would build a searchable online database. Proprietary blend details would stay confidential. Failure to comply would label products as misbranded.[3]
Durbin emphasized the need for basics. “FDA – and consumers – should know what dietary supplements are on the market and what ingredients are included in them,” he stated. “This is FDA’s most basic function, and the first step to protecting consumers.”[1][3]
Industry Split on Transparency Measure
Endorsements rolled in quickly. The Council for Responsible Nutrition called it a step toward openness. “Consumers deserve to know what products are on the market and what they contain – and FDA needs that same information to do its job effectively,” said CRN President Steve Mister.[3] Others backing the measure include the Consumer Federation of America, United States Pharmacopeia, U.S. PIRG, and Ritual.[1]
Critics voiced concerns. The Natural Products Association labeled it a “Trojan Horse” that circumvents DSHEA’s risk-based approach. NPA CEO Dan Fabricant warned it could stifle innovation and burden companies. The American Herbal Products Association and United Natural Products Alliance expressed reservations over impacts on small businesses and unclear benefits.[3]
Safety Alarms Heighten Urgency
The timing aligns with recent troubles. A Salmonella outbreak linked to Live it Up Super Greens powder prompted recalls. The product sold online, including at Walmart.[4]
Past scandals involved unlisted ingredients like tianeptine. Nine in 10 adults favor listing requirements, polls show.[1] The bill has surfaced before – in 2022 and 2024 – without passage. Now referred to the Senate Health, Education, Labor, and Pensions Committee, its fate remains uncertain in a divided Congress.[2]
Key Takeaways
- The act mandates product registration without premarket approval.
- A public database would list ingredients and claims for consumers.
- Supporters see gains in oversight; opponents fear overreach.
Supplements fill shelves and carts amid rising health awareness, yet oversight lags. Durbin’s effort spotlights a core question: Does basic listing enhance safety without upending a vital industry? What do you think? Share in the comments.
